VolitionRx Statistics
Total Valuation
VolitionRx has a market cap or net worth of $73.05 million. The enterprise value is $58.18 million.
| Market Cap | 73.05M |
| Enterprise Value | 58.18M |
Important Dates
The next estimated earnings date is Wednesday, May 8, 2024, after market close.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VolitionRx has 82.07 million shares outstanding. The number of shares has increased by 28.70% in one year.
| Shares Outstanding | 82.07M |
| Shares Change (YoY) | +28.70% |
| Shares Change (QoQ) | +1.63% |
| Owned by Insiders (%) | 23.92% |
| Owned by Institutions (%) | 7.97% |
| Float | 62.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 94.23 |
| Forward PS | 19.09 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 75.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.69
| Current Ratio | 0.69 |
| Quick Ratio | 0.66 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -158.37 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -154.20% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $7,048 |
| Profits Per Employee | -$321,083 |
| Employee Count | 110 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.66% in the last 52 weeks. The beta is 1.35, so VolitionRx's price volatility has been higher than the market average.
| Beta (1Y) | 1.35 |
| 52-Week Price Change | -43.66% |
| 50-Day Moving Average | 0.85 |
| 200-Day Moving Average | 0.95 |
| Relative Strength Index (RSI) | 61.31 |
| Average Volume (30 Days) | 174,732 |
Short Selling Information
The latest short interest is 493,617, so 0.60% of the outstanding shares have been sold short.
| Short Interest | 493,617 |
| Short Previous Month | 501,686 |
| Short % of Shares Out | 0.60% |
| Short % of Float | 0.79% |
| Short Ratio (days to cover) | 3.41 |
Income Statement
In the last 12 months, VolitionRx had revenue of $775,302 and -$35.32 million in losses. Loss per share was -$0.50.
| Revenue | 775,302 |
| Gross Profit | 775,302 |
| Operating Income | -35.99M |
| Pretax Income | -35.32M |
| Net Income | -35.32M |
| EBITDA | -33.68M |
| EBIT | -35.10M |
| Loss Per Share | -$0.50 |
Balance Sheet
The company has $20.73 million in cash and $5.86 million in debt, giving a net cash position of $14.87 million or $0.18 per share.
| Cash & Cash Equivalents | 20.73M |
| Total Debt | 5.86M |
| Net Cash | 14.87M |
| Net Cash Per Share | $0.18 |
| Equity / Book Value | -7.80M |
| Book Value Per Share | -0.10 |
| Working Capital | -9.98M |
Cash Flow
In the last 12 months, operating cash flow was -$18.06 million and capital expenditures -$1.08 million, giving a free cash flow of -$19.15 million.
| Operating Cash Flow | -18.06M |
| Capital Expenditures | -1.08M |
| Free Cash Flow | -19.15M |
| FCF Per Share | -$0.27 |
Margins
Gross margin is 100.00%, with operating and profit margins of -4,641.76% and -4,555.53%.
| Gross Margin | 100.00% |
| Operating Margin | -4,641.76% |
| Pretax Margin | -4,555.53% |
| Profit Margin | -4,555.53% |
| EBITDA Margin | -4,344.65% |
| EBIT Margin | -4,526.94% |
| FCF Margin | -2,469.59% |
Dividends & Yields
VolitionRx does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.70% |
| Shareholder Yield | -28.70% |
| Earnings Yield | -48.35% |
| FCF Yield | -26.21% |
Analyst Forecast
The average price target for VolitionRx is $3.75, which is 321.25% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.75 |
| Price Target Difference | 321.25% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 189.33% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
VolitionRx has an Altman Z-Score of -13.5 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.5 |
| Piotroski F-Score | 2 |